Playback speed
10 seconds
ASCO 2022 Birtamimab in Pts With Mayo Stage IV AL Amyloidosis: Rationale for Confirmatory Affirm-AL Phase 3 Study
By
ASCO 2022 Conference Coverage
FEATURING
Morie Gertz
By
ASCO 2022 Conference Coverage
FEATURING
Morie Gertz
0 views
June 14, 2022
Comments 0
Login to view comments.
Click here to Login